In adults, bone is the preferential target site for metastases from primary cancers of prostate, breast, lungs and thyroid. The tendency of these cancers to metastasize to bone is determined by the anatomical distribution of the blood vessels, by the genetic profile of the cancer cells and by the biological characteristics of the bone microenvironment that favour the growth of metastatic cells of certain cancers. Metastases to bone may have either an osteolytic or an ostoblastic phenotype. The interaction in the bone microenvironment between biological factors secreted by metastatic cells, and by osteoblasts and osteoclasts, and the osteolytic and osteoblastic factors released from the organic matrix mediate a vicious cycle characterized by metastatic growth and by ongoing progressive bone destruction. This interaction determines the phenotype of the metastatic bone disease. © 2011 Feller et al; licensee BioMed Central Ltd.
CITATION STYLE
Feller, L., Kramer, B., & Lemmer, J. (2011, July 27). A short account of metastatic bone disease. Cancer Cell International. https://doi.org/10.1186/1475-2867-11-24
Mendeley helps you to discover research relevant for your work.